Home The Word Brain My Amedeo FAQ Privacy About   


C49 + CC Journal Club

For more information, please refer to our special emails from April 13 and May 19.


  Liver Cirrhosis

  Free Subscription


21.04.2025

3 BMC Gastroenterol
2 Hepatology
2 Intern Med
7 J Hepatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Gastroenterol

  1. MOON SY, Son M, Kang YW, Koh M, et al
    Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea.
    BMC Gastroenterol. 2025;25:274.
    PubMed         Abstract available

  2. GUO Y, Su W, Tao L, Zhang G, et al
    The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study.
    BMC Gastroenterol. 2025;25:265.
    PubMed         Abstract available

  3. ZHOU Y, Lin H, Weng X, Dai H, et al
    Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis.
    BMC Gastroenterol. 2025;25:252.
    PubMed         Abstract available


    Hepatology

  4. HOLMER M, Ingre M, Farkkila M, Ponsioen C, et al
    Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.
    Hepatology. 2025 Apr 16. doi: 10.1097/HEP.0000000000001351.
    PubMed         Abstract available

  5. LUCAS MR, Pilling LC, Atkins JL, Melzer D, et al
    Incidence of liver complications with hemochromatosis associated HFE p.C282Y homozygosity: The role of central adiposity.
    Hepatology. 2024 Aug 23. doi: 10.1097/HEP.0000000000001056.
    PubMed         Abstract available


    Intern Med

  6. AMANO K, Sano T, Ide T, Nakano D, et al
    The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study.
    Intern Med. 2025;64:1133-1141.
    PubMed         Abstract available

  7. OEDA S, Inoue K, Isoda H, Hirai K, et al
    Survey on Awareness and Implementation Rate of Ultrasound Elastography and Attenuation Imaging.
    Intern Med. 2025;64:1143-1149.
    PubMed         Abstract available


    J Hepatol

  8. REIBERGER T, Maasoumy B
    Advancing our understanding of recompensated cirrhosis - the new "holy grail" of decompensated cirrhosis.
    J Hepatol. 2025 Apr 16:S0168-8278(25)00241-7. doi: 10.1016/j.jhep.2025.
    PubMed        

  9. TONON M, Gagliardi R, Pompili E, Barone A, et al
    Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease.
    J Hepatol. 2025 Apr 12:S0168-8278(25)00245-4. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available

  10. NAIK I, Yeo YH, Ng WH, Sheng-Kai Ma K, et al
    Carvedilol is Associated with Lower Risk of Hepatic Decompensation Compared to Other Non-Selective Beta-Blockers in Cirrhosis.
    J Hepatol. 2025 Apr 11:S0168-8278(25)00232-6. doi: 10.1016/j.jhep.2025.
    PubMed        

  11. SUN SS, Zhang J, Jin YP, Li L, et al
    A Rare Cause of Lipid Metabolism Disorder and Cirrhosis in an Adult.
    J Hepatol. 2025 Apr 9:S0168-8278(25)00227-2. doi: 10.1016/j.jhep.2025.
    PubMed        

  12. CALES P, Canivet CM, Costentin C, Lannes A, et al
    A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD.
    J Hepatol. 2025;82:794-804.
    PubMed         Abstract available

  13. ABDURRACHIM D, Lek S, Ong CZL, Wong CK, et al
    Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.
    J Hepatol. 2025;82:898-908.
    PubMed         Abstract available

  14. KIM HY, Rosenthal SB, Liu X, Miciano C, et al
    Multi-Modal Analysis of human Hepatic Stellate Cells identifies novel therapeutic targets for Metabolic Dysfunction-Associated Steatotic Liver Disease.
    J Hepatol. 2024 Nov 8:S0168-8278(24)02667-9. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.